FORT
LAUDERDALE, Fla., Nov. 30,
2022 /PRNewswire/ -- Psyrise, a mental health
marketing company located in South
Florida, has released a first-of-its-kind marketing platform
for health practitioners. The platform was previously used
internally by the company and piloted by a handful of select
practitioner partners. This broader release will now allow 25 more
groups to onboard as preferred partners.
Psyrise launched in January as the marketing arm inside of the
Nucleus ecosystem. Nucleus, wholly owned by Iter Investments, is a
venture studio building companies within the psychedelics industry
with a mission to connect people with the psychedelics industry.
Since launch, Psyrise has assisted over a dozen psychedelics
companies with marketing strategy and customer acquisition.
"Psyrise has always been much more than just a marketing
agency," said Nucleus CEO Logan
Lenz. "By leveraging the entire audience base across all of
the brands of Nucleus, Psyrise has positioned our partners as the
heroes of their own well-crafted stories. This platform now allows
us to distribute those stories even wider and allow for even more
practitioner heroes to experience the Psyrise boost."
Many of the ketamine clinics, therapists, coaches, and retreats
working within the Nucleus ecosystem have already grown accustomed
to what has been recognized as Psyrise's secret sauce. And that's
the team. With a combined 100+ years of marketing experience, the
growing Psyrise team has been happy to work with clients that save
lives within an industry that couldn't be more important right
now.
"We always have and always will put our partners first," said
Margaret Williamson, Head of
Partnerships for Psyrise/Nucleus. Whether you're a large clinic,
sole proprietor, or a retreat all the way across the globe, we've
developed the account management processes necessary to keep the
needle moving. Now that we are also rolling out our platform, our
partners will be able to expect even faster results."
Those results aren't just empty promises either. In Q3 alone,
Psyrise generated more than 17,000 leads for Nucleus and its
partners. In September, Nucleus moved to integrate the marketing
platform for all of its brands. Now the entire venture studio
tracks all of the ecosystem's metrics in one single platform -
Psyrise.
"We now have Psychedelic Invest, Psychedelic Finder, Neuly, and
all of our events being supported by the Psyrise platform," said
Lenz. "This means that any time a new user signs up to be a part of
our ecosystem, subscribes to a newsletter, or RSVPs for a
Psychedelic Series event, they're coming through Psyrise. This
makes our lives at Nucleus much simpler since we can now monitor
all activities and manage customer relationships in one place."
As of today, Psyrise has opened up spots for 25 more
practitioner partners to begin using its many features. Those
features include, but are not limited to:
- Marketing/vanity phone numbers
- SMS communications
- Customer Relationship Management
- Website Builder
- Form/Survey Builder
- Email Campaign Builder
- Workflow and Automation Builder
- Social Media Scheduler
- Customer Review Manager
- A Full Suite of Reports and Analytics
For more information, please visit www.psyrise.com and
www.withnucleus.com.
This press release (i) is not an offer, or solicitation of an
offer to buy or sell any security or investment, and (ii) does not
constitute tax, legal or investment advice.
About Psyrise
Psyrise is an end-to-end marketing platform built specifically
for ketamine clinics, retreats, therapists, and coaches. Psyrise
customers benefit from patient/guest acquisition and cost-effective
marketing strategies led by a team of experienced marketers. For
more information, visit www.psyrise.com.
About Nucleus
Nucleus is a venture studio for psychedelics. The mission of
Nucleus is to connect people with the psychedelics industry. The
brand accomplishes that through its many brands and assets built to
propel psychedelic-assisted therapy to the forefront. For more
information, visit www.withnucleus.com.
About Iter Investments
Iter Investments is an investment firm that deploys capital in
and around the burgeoning psychedelic industry. Iter Investments
invests with the mission of reimagining how the mental health and
wellness industry delivers care. For more information,
visit www.iterinvestments.com or email
contact@iterinvestments.com.
Media Contact:
Durée & Company, Inc.
954.723.9350 / 349707@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/psyrise-launches-the-first-end-to-end-marketing-platform-for-ketamine-clinics-retreats-and-psychedelic-assisted-therapists-301689962.html
SOURCE Nucleus / Psyrise